Artigo Acesso aberto Revisado por pares

Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma

2019; Nature Portfolio; Volume: 574; Issue: 7780 Linguagem: Inglês

10.1038/s41586-019-1650-0

ISSN

1476-4687

Autores

Hiromichi Suzuki, Sachin Kumar, Shimin Shuai, Ander Díaz‐Navarro, Ana Gutiérrez‐Fernández, Pasqualino de Antonellis, Florence M.G. Cavalli, Kyle Juraschka, Hamza Farooq, Ichiyo Shibahara, Maria C. Vladoiu, Jiao Zhang, Namal Abeysundara, David Przelicki, Patryk Skowron, Nicole Gauer, Betty Luu, Craig Daniels, Xiaochong Wu, Antoine Forget, Ali Momin, Jun Wang, Weifan Dong, Seung-Ki Kim, Wiesława Grajkowska, Anne Jouvet, Michelle Fèvre‐Montange, Maria Luisa Garrè, Amulya A. Nageswara Rao, Caterina Giannini, Johan M. Kros, Pim J. French, Nada Jabado, Ho‐Keung Ng, Wai Sang Poon, Charles G. Eberhart, Ian F. Pollack, James M. Olson, William A. Weiss, Toshihiro Kumabe, Enrique López‐Aguilar, Bolesław Lach, Maura Massimino, Erwin G. Van Meir, Joshua B. Rubin, Rajeev Vibhakar, Lola B. Chambless, Noriyuki Kijima, Álmos Klekner, László Bognár, Jennifer A. Chan, Cláudia C. Faria, Jiannis Ragoussis, Stefan M. Pfister, Anna Goldenberg, Robert J. Wechsler‐Reya, Swneke D. Bailey, Livia Garzia, A. Sorana Morrissy, Marco A. Marra, Xi Huang, David Malkin, Olivier Ayrault, Vijay Ramaswamy, Xosé S. Puente, John A. Calarco, Lincoln Stein, Michael D. Taylor,

Tópico(s)

Renal and related cancers

Resumo

In cancer, recurrent somatic single-nucleotide variants—which are rare in most paediatric cancers—are confined largely to protein-coding genes1–3. Here we report highly recurrent hotspot mutations (r.3A>G) of U1 spliceosomal small nuclear RNAs (snRNAs) in about 50% of Sonic hedgehog (SHH) medulloblastomas. These mutations were not present across other subgroups of medulloblastoma, and we identified these hotspot mutations in U1 snRNA in only G mutations are identified in U1 splicesomal small nuclear RNAs in about 50% of Sonic hedgehog medulloblastomas, which result in disrupted RNA splicing and the activation of oncogenes.

Referência(s)